ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Vor Biopharma Inc

Vor Biopharma Inc (VOR)

0.675
0.0155
( 2.35% )
更新日時: 22:33:10

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.675
買値
0.675
売値
0.69
出来高
31,320
0.675 日の範囲 0.6895
0.638 52 週間の範囲 3.1399
時価総額
前日終値
0.6595
始値
0.68
最終取引時間
22:33:10
財務取引量
US$ 21,296
VWAP
0.679946
平均取引量 (3 か月)
840,687
発行済株式数
68,398,826
配当利回り
-
PER
-0.38
1 株当たり利益 (EPS)
-1.72
歳入
-
純利益
-117.86M

Vor Biopharma Inc について

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker VOR. The last closing price for Vor Biopharma was US$0.66. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0.638 to US$ 3.1399.

Vor Biopharma currently has 68,398,826 shares in issue. The market capitalisation of Vor Biopharma is US$45.11 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.38.

VOR 最新ニュース

Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer

CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Han Choi, M.D., LL.M., as its...

New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with...

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.085-11.18421052630.760.79930.6388300080.67441923CS
4-0.1825-21.28279883380.85751.190.63820223370.89805509CS
12-0.2926-30.23976849940.96761.190.6388406870.90369146CS
26-1.385-67.23300970872.062.230.6385716601.06456846CS
52-1.275-65.38461538461.953.13990.6383997111.35990421CS
156-14.885-95.661953727515.5618.5150.6382203173.21508915CS
260-41.345-98.393622084742.0263.620.6382148787.30528465CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 10.74
(0.00%)
223.84k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 63.55
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.96
(0.00%)
1
AACGATA Creativity Global
US$ 0.8955
(0.00%)
592
AALAmerican Airlines Group Inc
US$ 10.74
(0.00%)
223.84k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 63.55
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.96
(0.00%)
1
AACGATA Creativity Global
US$ 0.8955
(0.00%)
592
ELABElevai Labs Inc
US$ 0.0852
(0.00%)
168.36M
PEGYPineapple Energy Inc
US$ 0.1149
(0.00%)
98.7M
MLGOMicroAlgo Inc
US$ 0.31
(0.00%)
41.06M
CDTConduit Pharmaceuticals Inc
US$ 0.095
(0.00%)
27M
XPONExpion360 Inc
US$ 0.0466
(0.00%)
10.89M

VOR Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock